859 related articles for article (PubMed ID: 15050820)
1. Molecular evolution of the histone deacetylase family: functional implications of phylogenetic analysis.
Gregoretti IV; Lee YM; Goodson HV
J Mol Biol; 2004 Apr; 338(1):17-31. PubMed ID: 15050820
[TBL] [Abstract][Full Text] [Related]
2. HDAC family: What are the cancer relevant targets?
Witt O; Deubzer HE; Milde T; Oehme I
Cancer Lett; 2009 May; 277(1):8-21. PubMed ID: 18824292
[TBL] [Abstract][Full Text] [Related]
3. Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors.
Khan N; Jeffers M; Kumar S; Hackett C; Boldog F; Khramtsov N; Qian X; Mills E; Berghs SC; Carey N; Finn PW; Collins LS; Tumber A; Ritchie JW; Jensen PB; Lichenstein HS; Sehested M
Biochem J; 2008 Jan; 409(2):581-9. PubMed ID: 17868033
[TBL] [Abstract][Full Text] [Related]
4. Screening of histone deacetylases (HDAC) expression in human prostate cancer reveals distinct class I HDAC profiles between epithelial and stromal cells.
Waltregny D; North B; Van Mellaert F; de Leval J; Verdin E; Castronovo V
Eur J Histochem; 2004; 48(3):273-90. PubMed ID: 15590418
[TBL] [Abstract][Full Text] [Related]
5. Histone deacetylase genes in Arabidopsis development.
Hollender C; Liu Z
J Integr Plant Biol; 2008 Jul; 50(7):875-85. PubMed ID: 18713398
[TBL] [Abstract][Full Text] [Related]
6. The emerging role of class II histone deacetylases.
Fischle W; Kiermer V; Dequiedt F; Verdin E
Biochem Cell Biol; 2001; 79(3):337-48. PubMed ID: 11467747
[TBL] [Abstract][Full Text] [Related]
7. Substrate and inhibitor specificity of class 1 and class 2 histone deacetylases.
Hildmann C; Wegener D; Riester D; Hempel R; Schober A; Merana J; Giurato L; Guccione S; Nielsen TK; Ficner R; Schwienhorst A
J Biotechnol; 2006 Jun; 124(1):258-70. PubMed ID: 16567013
[TBL] [Abstract][Full Text] [Related]
8. Class I histone deacetylase expression has independent prognostic impact in human colorectal cancer: specific role of class I histone deacetylases in vitro and in vivo.
Weichert W; Röske A; Niesporek S; Noske A; Buckendahl AC; Dietel M; Gekeler V; Boehm M; Beckers T; Denkert C
Clin Cancer Res; 2008 Mar; 14(6):1669-77. PubMed ID: 18347167
[TBL] [Abstract][Full Text] [Related]
9. Histone deacetylases--an important class of cellular regulators with a variety of functions.
Hildmann C; Riester D; Schwienhorst A
Appl Microbiol Biotechnol; 2007 Jun; 75(3):487-97. PubMed ID: 17377789
[TBL] [Abstract][Full Text] [Related]
10. Toward selective histone deacetylase inhibitor design: homology modeling, docking studies, and molecular dynamics simulations of human class I histone deacetylases.
Wang DF; Helquist P; Wiech NL; Wiest O
J Med Chem; 2005 Nov; 48(22):6936-47. PubMed ID: 16250652
[TBL] [Abstract][Full Text] [Related]
11. The class I histone deacetylases of the platyhelminth parasite Schistosoma mansoni.
Oger F; Dubois F; Caby S; Noël C; Cornette J; Bertin B; Capron M; Pierce RJ
Biochem Biophys Res Commun; 2008 Dec; 377(4):1079-84. PubMed ID: 18977200
[TBL] [Abstract][Full Text] [Related]
12. Transcription regulation by histone deacetylases.
Wang S; Yan-Neale Y; Zeremski M; Cohen D
Novartis Found Symp; 2004; 259():238-45; discussion 245-8, 285-8. PubMed ID: 15171258
[TBL] [Abstract][Full Text] [Related]
13. Nuclear histone deacetylases are not required for global histone deacetylation during meiotic maturation in porcine oocytes.
Endo T; Kano K; Naito K
Biol Reprod; 2008 Jun; 78(6):1073-80. PubMed ID: 18305223
[TBL] [Abstract][Full Text] [Related]
14. HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics.
Gallinari P; Di Marco S; Jones P; Pallaoro M; Steinkühler C
Cell Res; 2007 Mar; 17(3):195-211. PubMed ID: 17325692
[TBL] [Abstract][Full Text] [Related]
15. Chromosomal organization and localization of the novel class IV human histone deacetylase 11 gene.
Voelter-Mahlknecht S; Ho AD; Mahlknecht U
Int J Mol Med; 2005 Oct; 16(4):589-98. PubMed ID: 16142391
[TBL] [Abstract][Full Text] [Related]
16. Acetylation of proteins as novel target for antitumor therapy: review article.
Di Gennaro E; Bruzzese F; Caraglia M; Abruzzese A; Budillon A
Amino Acids; 2004 Jul; 26(4):435-41. PubMed ID: 15290351
[TBL] [Abstract][Full Text] [Related]
17. Histone deacetylase inhibitors: molecular mechanisms of action.
Xu WS; Parmigiani RB; Marks PA
Oncogene; 2007 Aug; 26(37):5541-52. PubMed ID: 17694093
[TBL] [Abstract][Full Text] [Related]
18. Teratogenic effects mediated by inhibition of histone deacetylases: evidence from quantitative structure activity relationships of 20 valproic acid derivatives.
Eikel D; Lampen A; Nau H
Chem Res Toxicol; 2006 Feb; 19(2):272-8. PubMed ID: 16485903
[TBL] [Abstract][Full Text] [Related]
19. The human histone deacetylase family.
Gray SG; Ekström TJ
Exp Cell Res; 2001 Jan; 262(2):75-83. PubMed ID: 11139331
[TBL] [Abstract][Full Text] [Related]
20. Role of histone deacetylase inhibitors in the treatment of cancer (Review).
Mei S; Ho AD; Mahlknecht U
Int J Oncol; 2004 Dec; 25(6):1509-19. PubMed ID: 15547685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
